Written By: Jamie Hope - Methyl-Life Founder Please subscribe to get more content like this sent to your inbox
We require improved evidence on pharmacokinetics, safety thresholds, and the effects of prolonged exposure
A randomized, double-blind, placebo-controlled phase II study (MOT114479) to evaluate the safety and efficacy and dose response of 28 days of orally administered camicinal, a motilin receptor agonist, in diabetics with gastroparesis
It exerts potent antioxidant effects, modulates cellular signaling, and supports cognitive function, cell viability, and adaptation to stress
One aspect of MS pathogenesis is a disruption in brain energy metabolism, which potentially could result in the development of depression (17)
Estrogen mediates acute elastic fibre homeostasis in skin